Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 70,857 | 78,062 | 55,742 | 60,809 | 62,001 |
| Marketable Securities | 1,173 | 1,882 | 2,616 | 4,295 | 6,745 |
| Receivables | 707 | 515 | 50,840 | 79 | 326 |
| TOTAL | $74,026 | $81,872 | $111,549 | $68,344 | $71,577 |
| Non-Current Assets | |||||
| PPE Net | 3,869 | 4,548 | 4,872 | 4,728 | 5,008 |
| Intangibles | 57,429 | 57,461 | 57,494 | 57,526 | 57,559 |
| Other Non-Current Assets | 598 | 639 | 630 | 614 | 610 |
| TOTAL | $61,896 | $62,648 | $62,996 | $62,868 | $63,177 |
| Total Assets | $135,922 | $144,520 | $174,545 | $131,212 | $134,754 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,684 | 8,957 | 27,969 | 6,705 | 5,348 |
| Other current liabilities | 15,785 | 14,886 | 197 | 293 | N/A |
| TOTAL | $25,091 | $24,593 | $47,116 | $8,791 | $6,768 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 18,119 | 975 | 613 |
| Other Non-Current Liabilities | 1,482 | 1,792 | 2,171 | 50 | 2,470 |
| TOTAL | $29,332 | $34,709 | $36,531 | $2,832 | $4,385 |
| Total Liabilities | $54,423 | $59,302 | $83,647 | $11,623 | $11,153 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 169,756 | 169,727 | 169,709 | 168,558 | 167,460 |
| Common Shares | 437,151 | 435,818 | 434,529 | 432,250 | 428,046 |
| Retained earnings | -350,947 | -344,184 | -337,097 | -308,105 | -300,282 |
| Other shareholders' equity | -4,705 | -6,416 | -6,534 | -4,556 | -4,163 |
| TOTAL | $81,499 | $85,218 | $90,898 | $119,589 | $123,601 |
| Total Liabilities And Equity | $135,922 | $144,520 | $174,545 | $131,212 | $134,754 |